Q1 2025 Earnings Call Transcript May 6, 2025 Krystal Biotech, Inc. misses on earnings expectations. Reported EPS is $1.2 EPS, expectations were $1.38. Operator: Thank you for standing by, and welcome ...

Q3 2025 Earnings Call Transcript May 7, 2025 Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.56, ...

DALLAS - Oregon Ducks coach Dan Lanning beamed with pride and gratitude as he received the prestigious Stallings Award for humanitarianism at the Dallas Country ...

Thank you for standing by, and welcome to the Krystal Biotech First Quarter 2025 Earnings Call. At this time, all participants are on a listen-only mode. After the speakers' presentations, there will ...

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...

Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...

Neurocrine Biosciences has handed back two discovery-stage gene therapy programs to Voyager Therapeutics, although the companies’ wider central-nervous-system-focused collaboration remains on track.

The FDA has approved Abeona Therapeutics’ prademagene zamikeracel (Zevaskyn) gene therapy for recessive dystrophic epidermolysis bullosa (DEB), a rare genetic skin disease. Prademagene ...

Researchers from The University of Osaka found that mass photometry can accurately distinguish full and empty rAAV particles ...

New breakthrough data from studies evaluating the vector (research code S01coAAV2) have been selected for presentation as a Late-Breaking Abstract at the 2025 American Society of Gene & Cell Therapy ...